\
&
Contact us
\
&
Contact us
This was 2 years ago
LocationLouvain-la-Neuve
The Belgian Association for Public Health's Symposium this year is all about working together on the challenges and future of public health in Belgium.
The morning of the symposium will be organized around four plenary sessions and a debate during which Belgian and international speakers will discuss public health challenges in Belgium and Europe. The afternoon will be structured around various workshops led by experts. Several networking opportunities will also be planned during the day.
One of the workshops on the agenda is about 'Funding for public health research', with with experts from BELSPO, FNRS, FWO, Horizon Europe Cluster 1 Health programme and the Belgian Health Care Knowledge Center (KCE).
More information and registration on the event website. Please note that registration is closing soon!
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
